Japanese reimbursements fail to send the right signals to orthopaedic manufacturers
This article was originally published in Clinica
Executive Summary
In Japan, orthopaedic products are classified into a few broad reimbursement categories. More specific categories and greater flexibility could free the market and close the so-called device gap, writes Derrick Buddles, member of the AMDD Orthopaedics Committee